At 56-month follow-up, abdominal CT detected new hepatic lesions, which pathological and immunohistochemical examinations confirmed as <i>de novo</i> HCC rather than iCCA recurrence, with the patient remaining AFP-negative throughout the course. The gene discussed is AFP; the disease is hepatocellular carcinoma.